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Abstract
Since the 1950s, the medical community has been faced with infectious diseases, 
which have brought significant public health and financial challenges. Currently, rou-
tine testing for the laboratory diagnosis for infectious agents is based on cell culture, 
serological, and molecular methods. However, cell culture-based methods are used 
mainly in research laboratories and are less sensitive methods when compared with 
serological and molecular methods. The diagnosis of infectious diseases has been rev-
olutionized by the development of molecular techniques, mainly with the applications 
of polymerase chain reaction (PCR). The high sensitivity, specificity, and ease with 
which the PCR can be used to detect genetic sequences known have led to your wide 
application in science. A great number of qualitative and quantitative molecular assays 
are mostly based on what have been described such as real-time PCR, multiplex PCR, 
LAMP-PCR, and digital PCR. These assays could identify active infection by detecting 
infectious agents and nucleic acid in various clinical conditions including arboviruses, 
sexually transmitted infections, and bacterial infections. Further advancement of 
molecular technology is needed to improve the capacity to detect infectious agents in 
order to control the spread of infectious diseases and lead to appropriate actions which 
help to benefit patients and health-care workers themselves.
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1. Introduction
Infectious diseases (ID) are caused by pathogenic microorganisms, such as bacte-
ria, viruses, parasites, or fungi, and the diseases can be spread, directly or indirectly, 
from one person to another. Scientific advances in the biomedical area since the first 
half of last century, represented by the development of therapeutic drugs, vac-
cines, and advanced sanitation technologies, were carried as result of the control or 
prevention of infectious diseases. These diseases are considered, at the global level, 
as some of the most common public health problems. The relevance of these patholo-
gies is evidenced by the number of individuals reached, the lack of knowledge about 
the infectious agents, their socioeconomic impact, the deepening of the molecular 
studies involving a precise and fast diagnosis, and appeals public health agency 
studies aimed at the development of diagnostic techniques for the early detection of 
symptomatic carriers as well as the asymptomatic carriers of these infections.
Changes in society, technology, and the microorganisms themselves are con-
tributing to the emergence of new diseases, the reemergence of diseases once 
controlled, and to the development of antimicrobial resistance. According to the 
World Health Organization (WHO), the IDs constitute a significant proportion of 
all human diseases known, and at least 25% of about 60 million deaths that occur 
worldwide each year are estimated to be due to infectious diseases [1, 2].
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Scientific studies of infectious agents and diseases provide a knowledge for the 
development of diagnostic tests for such diseases, drugs to treat, and vaccines for 
prevention. Earlier, specific and effective diagnosis is one of the most appropriate 
forms and strategies for managing. According to [3], in American hospitals, about 
5 million cases of infectious disease are reported annually. Besides that, most of the 
cases are unreported, resulting in substantial morbidity and mortality [3]. In the 
last 20 years, analysis methods based on the detection and sequencing of 16S rDNA 
have been widely used in place of conventional culture methods.
Unfortunately, despite in clinical laboratories, the diagnosis of infectious diseases is 
directly associated with time of pathogen identification by conventional culture meth-
ods as these tests suffer from long turnaround times, from hours to days. A technical 
difficulty encountered in these methods performed before the advent of the molecular 
techniques was that not all pathogens are cultivable, and culture conditions ordinarily 
are not known. Other limitations of the traditional diagnostic include requirements for 
additional testing and wait times for characterizing detected pathogens (i.e., discern-
ment of species, virulence factors, and antimicrobial resistance) [3, 4].
Nucleic acid amplification is one of the most valuable tools in virtually all life 
science fields, including application-oriented fields such as clinical medicine, for 
diagnosis of infectious diseases.
The serological methods are limited by the cross-reactions between the types of 
agents and by the fact that some infectious agents have no clearly identified epitopes 
that are sufficiently specific, requiring them as a stringent clinic diagnostic. In addi-
tion, the specific IgM antibodies are detected only in acute phase of infection, and 
for detecting infections, the serological tests are inaccurate, labor-intensive, and 
unreliable. In the last 20 years, analysis methods based on the nucleic acid amplifi-
cation have been widely used in all life science fields as a new way for the diagnosis 
of human pathogens like virus, bacteria, and parasites.
The use of amplification techniques such as Polymerase Chain Reaction (PCR) 
has long been used to detection, genotyping, and quantification of virus and bac-
teria in various clinical specimens, such as serum, plasma, urine, semen, and liquid 
cerebrospinal fluid (CSF).
PCR-based diagnostics have been effectively developed for a wide range of micro-
organisms. Due to its incredible sensitivity, specificity, reproducibility, broad dynamic 
range, and speed of amplification, PCR has been championed by infectious disease 
experts for identifying organisms that cannot be grown in vitro, or in instances where 
existing culture techniques are insensitive and/or need prolonged incubation times [5].
Advances in development of molecular technology and diagnostics have 
enhanced understanding IDs’ etiology, pathogenesis, and molecular epidemiology, 
which provide basis for appropriate detection, quantification, prevention, and 
control measures as well as rational design of vaccine, by which some diseases have 
been successfully eliminated.
Since 1985, many PCR amplification-based techniques have been designed for 
detection and identification, including: multiplex PCR (M-PCR), LAMP-PCR, 
digital PCR (dPCR), and real-time PCR.
2.  PCR techniques and clinical applications in diagnostic of infectious 
disease
2.1 Multiplex PCR
In diagnostic laboratories, the use of PCR is often limited by its cost and some-
times by the availability of adequate sample volume. To overcome these issues and 
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also to increase the diagnostic capacity of PCR, there is a type termed multiplex 
PCR (mPCR). The mPCR refers to the use of different pairs of primers to simulta-
neously amplify multiple regions of the nucleic acid of the sample with visualiza-
tion of the amplified products by gel electrophoresis. The use of multiple primer 
pairs in mPCRs is an innovation that offers significant benefits in cost, time, and 
exact diagnosis. The main advantage of this technology is to minimize the number 
of separate reactions, for example, to detect several pathogens at the same time in a 
single specimen such as sexually transmitted pathogens [6–8]. This technique makes 
it possible to diagnose several diseases with a single diagnostic test, with sensitivity, 
specificity, and speed, indispensable values in diagnostic tests.
This technique has become a mainstay of research and clinical diagnostic 
applications, such as sexually transmitted infections (STIs). Considering a major 
public health problem, the STIs are common everywhere from developed countries 
and developing countries. It is estimated that each year more than 340 million new 
cases of bacterial STI arise, including gonorrhea, chlamydia, and syphilis, and the 
incidence is increased worldwide in adults of 15–49 years of age [9]. The suscepti-
bility to sexually transmitted infections, including the human immunodeficiency 
virus (HIV), and the high cost of treatment have led to the need for fast and reliable 
laboratory techniques for the identification of pathogens. Procedures for nucleic 
acid amplification to detect sexually transmitted pathogens have been developed, 
especially mPCR methods [10].
The multiplex PCR has the potential to analyze many samples in a single reac-
tion, and it is useful for diagnostic of multipathogenic infection. However, it has 
some limitations such as the nonspecific products generated through primer-primer 
interactions that may interfere with the amplification of targets, decreasing sensi-
tivity, and selectivity of reactions.
2.2 Loop-mediated isothermal amplification
Nucleic acid amplification is commonly used in the field of life science research. 
With the development of molecular biology, many new molecular diagnostic 
technologies have been developed subsequently [11].
The loop-mediated isothermal amplification (LAMP-PCR) was first developed 
over 15 years ago, and it has emerged as powerful method to concurrently detect 
multiple pathogens [12, 13]. The method employs a DNA polymerase with strand 
displacement activity and a set of four inner and outer primers that recognize a 
total of six distinct sequences of the target DNA. Moreover, the method involves 
two successive steps of amplification, with the first step comprising mPCR and the 
second step LAMP. Amplicons of the first step serve as templates in the second step. 
The amplification protocol requires only a single temperature for the reaction, and 
the amplification is diagnosed without the need for electrophoretic techniques, 
using in situ detection process with colorimetric dye or with a fluorescent dye. The 
final products are the accumulation of 109 copies of target DNA in less than an hour. 
The LAMP-PCR has been regarded as an innovative technology and emerged as 
an alternative to PCR-based methodologies in clinical laboratory with significant 
increase of detection limits, efficiency, selectivity, and specificity over single-stage.
With more and more scientists focusing their attention on the application 
of LAMP technology, the range of its use is not limited to the bacteria detection 
and identification any more [14]. The LAMP-PCR was developed and employed 
to detect species that cause chorioamnionitis and premature labor, Ureaplasma 
parvum, and Ureaplasma urealyticum [15].
It was also applied to the parasite and virus detection [16–18]. Recently, Kurosaki 
et al. in their study [19] in 2017 developed a LAMP-PCR assay for the detection of 
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Zika virus plasma, serum, and urine samples collected from 120 suspected cases of 
arbovirus infection in Brazil.
2.3 Real-time PCR
According to [20], clinical diagnostic approaches rely on quantitative PCR 
(qPCR) as a method to detect and quantify infectious agents. Fluorescence chemis-
try-based methods have revolutionized molecular diagnostics and become the gold 
standard for viral load quantification and detection of bacterial and viral patho-
gens. During qPCR, the nucleic acid is amplified until it produces a certain level 
of signal which is supplied through a DNA intercalating dye or sequence-specific 
fluorescent probe. The cycle threshold (Cq), defined as the number of amplifica-
tion cycles required to reach that signal level, is used to calculate the number of 
target molecules originally present based on a standard curve [20]. In qPCR, the 
targets are detected in real time from the sealed PCR plate, and there is no post-PCR 
processing required; therefore, the risk of false-positive results due to amplicon 
carryover is substantially decreased compared to conventional [21].
During the past decade, advantages on PCR have become gold standard pro-
cedure in the diagnosis of infectious diseases, particularly the diagnosis of viral 
diseases, such as arboviruses. Arboviruses are causing an unprecedented health 
calamity in world, especially in Latin American countries, with rising statistics on 
a daily basis. The diagnosis of these diseases is difficult to establish only by clinical 
features. A substantial proportion of these infections are asymptomatic, but some 
patients may also present clinical symptoms similar to the arboviruses such as those 
caused by the Dengue, Zika, and Chikungunya virus. The qPCR technique is more 
sensitive and specific than serological tests. Besides that, in serum samples, it is 
only possible to perform the diagnosis in the acute phase of the disease that lasts up 
to 4–7 days after the onset of symptoms. In relation to the detection of Zika virus 
(ZIKV), for example, recent data from the literature indicate that in human urine, 
viral RNA was found longer compared to serum, up to 20 days after the onset of the 
first symptoms. In semen, studies show that the genetic material of ZIKV was found 
for weeks and even months after infection [22]. However, the determination of 
viral load presents some particular challenges when using qPCR methodology. This 
is because reliable absolute concentration results of qPCR are dependent on assay 
efficiency, instrument calibration metrics, and comparison with a known reference 
sample to convert the Cq measurements to a sample unknown.
2.4 Digital PCR
In contrast to qPCR, the digital PCR (dPCR) uses an alternative method that is 
not dependent upon the determination of the amplification cycle that the reporter 
dye signal exceeds a threshold. Instead, prior to amplification, the samples to be 
subjected to dPCR are divided into thousands of independent PCR reactions and 
are scored as either positive or negative for amplification of the viral sequence of 
interest. The positive wells are counted and converted to a target concentration in 
the original sample. This binary assignment of each reaction greatly minimizes the 
dependence of measurement on parameters such as the efficiency of the assay and 
the calibration of the instrument. Therefore, dPCR is the absolute quantification 
methodology with the greatest potential for quantification of low-load viral nucleic 
acids.
In the diagnostic routine, it is very common to obtain positive qPCR results 
obtained at the detection limit of this methodology, which may generate uncer-
tainty of the result. dPCR is a complementary methodology that works beyond 
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the limit of detection of qPCR, since it is based on the Poisson distribution. 
Consequently, this methodology has a significant impact on research as well as on 
diagnostic applications [23–25].
Some benefits of digital PCR in virology can be cited [25]:
• Quantification of viral genomes in samples without the need to use a standard 
curve;
• Detection of viruses that have a very low viral load;
• Use of low concentration of samples;
• Reduction of the impact of inhibitors present on complex samples.
Table 1 shows a comparison between the two methodologies: qPCR and dPCR.
A great number of studies use dPCR to diagnose infectious disease-related 
viruses, including hepatitis B virus (HBV), cytomegalovirus, human influenza, and 
HIV [26–28]; bacterial infections (Mycobacterium tuberculosis, Chlamydia trachomatis, 
and Staphylococcus aureus) [29–31]; and parasitic infectious such as detection of 
Plasmodium falciparum and Plasmodium vivax [32].
3. Conclusions
The ability to concurrently detect multiple pathogens infecting a host is crucial 
for accurate diagnosis of infectious diseases, identification of coinfections, and 
assessment of disease state for an effective patient management. PCR technology 
has been widely used to detect and quantify pathogenic microorganisms that cause 
various infectious diseases including some arboviruses, STIs, and bacterial infec-
tion. This methodology is revolutionizing the area of molecular diagnostics because 
of its high sensitivity of detection and specificity for the determination of infec-
tious agents. In addition, there is a reduction in run time and cost over traditional 
cultivation methods, for example, to determine the amount of a particular pathogen 
in a clinical specimen. The main advantages of PCR are its higher sensitivity and 
specificity compared with other diagnostic methods such as serological assays and 
culture methods, as well as its rapidity, utility, and versatility in clinical laboratory.
Although the conventional PCR is the most widely used molecular technique, 
other methodologies have been developed including real-time PCR, multiplex PCR, 
LAMP-PCR, and digital PCR. The biochemical mechanisms of these techniques are 
based on enzyme-mediated processes, target, signal or probe amplification, and 
isothermal conditions.
qPCR dPCR
Results Cq, ∆Cq, or ∆∆Cq Copies/mL
Quantification Relative quantification Absolut quantification, without standard 
curve




Comparative analysis between RT-qPCR and dPCR.
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Considering the clinical importance of these diseases, the number of infected 
individuals worldwide and the serious health consequences for population is 
extremely relevant to the precise, rapid, and sensitive diagnosis of these diseases in 
laboratories. Regardless, there is still the need for advances in basic science research 
and development of molecular technologies, which provide basis for the precise 
diagnostic and molecular epidemiology of infectious diseases as well as control 
measures, prevention, and design of vaccines and monitoring of infections face-to-
face the treatment applied in clinical practice.
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